3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Active not recruiting
2
Withdrawn
1
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Neuroendocrine Tumors
3
Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
lutetium Lu 177 dotatate
1
lanreotide
1
folfirinox
1
famitinib
1
Octreotide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Cytokines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Gastro-enteropancreatic neuroendocrine tumor
×
lutetium Lu 177 dotatate
×
Clear all
NCT05987176
2026-01-14
NELMAS
Imperial College London
Phase 2
Terminated
1 enrolled